Ishita Drugs & Industries Ltd — Board Meeting, 13-06-2025: Board Meeting

Ishita Drugs & Industries Ltd has announced a board meeting where it was disclosed that the company is upgrading its manufacturing facility at Sanand to comply with the Revised Schedule M to the Drug Rules, 1945. Consultants have been appointed, and the design and layout of the upgraded facility have been approved by the regulatory authority. Implementation has begun as per the approved plan. The company has also applied for an extension in the implementation timeline. This upgrade aims to ensure compliance and potentially improve operational standards, which is important for maintaining product quality and regulatory standing.